We look for potentially undervalued stocks in biotech, technology, and commodities sectors.
We perform research, and give investment opinions and ideas to buy-side firms from time to time.
We do not discuss unpublished reports, or provide any advanced warning of future reports to others.
We are not advisors.
Robert M. Maltbie, is a Managing Director of Millennium Asset Management and holds a controlling interest in the General Partnership. Robert began his career as an investment adviser with Morgan Stanley Dean Witter in 1988 and later joined Spear Financial in 1992 where he created and managed its equity research department. In 1994 Robert joined Salomon Smith Barney in Beverly Hills, California where he managed growth portfolios for private and institutional clients . He later founded Millennium Asset Management in 1999 and started its flagship fund Argonaut 2000 Partners, L.P. for accredited investors and institutions.
Robert graduated from UCLA with a Bachelor of Arts degree in Political Science in 1981. He has also earned the Chartered Financial Analyst designation and is a member of the Association for Investment Management and Research.
Robert has also been featured in Forbes and has contributed investment advice regularly to several Los Angeles-based financial media. His investment strategies have also been frequently featured in Investor’s Business Daily.
Mark R. Hake, CFA is Chief Strategy Officer at ZipRemit, Inc., a financial online lending firm and asset manager. Previously he was President of Hake Investment Research and Hake Capital Management. He has been featured in Barron’s, CNBC, Bloomberg and other news organizations as a contrarian investor and deep value specialist.
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
I am a retired global analyst, currently busy in investing and writing articles about stocks at several investing publications and websites. I have also developed strategies for creating winning portfolios according to specific formulas.
In January 2015, I was ranked among the world’s top 10 financial bloggers according to TipRanks, which holds financial experts accountable for their recommendations by disclosing their stock ratings since 2009:
The Fraud Research Institute ("FRI") specializing in the research and discovery of financial scandals and corporate malpractice in the United States with an emphasis on the small cap markets.
Our business model is to publish the highest quality and most compelling professional research reports that highlight all material information necessary for short-biased traders to identify superior risk-to-reward trade ideas that are primarily a result of market inefficiencies created by the artificial demand from stock promotion (pump & dump) campaigns.
We identify Wall Street's biggest frauds and profit from them.
Active manager of micro cap and small cap opportunities. Proprietary trend following based system of risk management for your speculative allocations. 100 percent technical, trend following system.
During the IPO season Francis Gaskins, editor of IPOdesktop.com & director of research for Equities.com, regularly appears on CNBC TV, Bloomberg, thestreet.com & other financial cable channels. On the day of the Visa IPO he appeared on four cable TV financial shows including Bloomberg & CNBC.
Over the past five years he has been quoted over 500 times by such financial media as the Wall Street Journal, Bloomberg, Reuters, Associated Press, USA Today among others. Those quotes are available at IPOdesktop.com.
His varied personal interests include violin playing. For example, he is concertmaster of the Palisades Symphony. He also holds an MBA from Harvard Business School (finance) and an AB from Princeton University (economics).
Portfolio manager delivering alpha principally through the discovery of under-the-radar small cap names with compelling stories misunderstood/underappreciated by the market.
Gotham City Research LLC focuses on due diligence-based, special situation investing. As of the publication date of our articles, we may have long or short equity positions in the companies covered. http://www.gothamcityresearch.com
As a seasoned, long term and profitable trader I’ve had the opportunity and privilege to know, interact, and learn from traders with vast degrees of experience and knowledge. I have learned so much from listening, asking questions, and sharing my knowledge in an effort to become even more profitable and now, to help mentor others who are interested in our art and to dispel myths about “day traders” or trading the markets. Once or twice a week we will be talking about the stocks that are working on Wall Street right now and a little trading lesson will be incorporated.
As a seasoned, battle-tested, scarred, and profitable trader I’ve had the opportunity and privilege to know, interact, and learn from traders with vast degrees of experience and knowledge. I have learned so much from listening, asking questions, and sharing my knowledge in an effort to become even more profitable and now, to help mentor others who are interested in our art and to dispel myths about “day traders” or trading the markets. Once or twice a week we will be talking about the stocks that are working on Wall Street right now and a little trading lesson will be incorporated.
Paul is a stock investor with an accounting/finance background. He likes to look for value growth stocks and momentum news plays. He is also known as Superman on Twitter @super_trades and his blog is www.super-trades.com (http://www.super-trades.com).